Everest Organics Balance Sheet Annual

Trade

BSE: 524790 | NSE: - | ISIN: INE334C01029 | Sector: Biotechnology & Drugs

142.80 +7.20 (5.31%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.27	0.27	0.11	0.51
Short Term Investments	0.20	0.00	0.00	-
Cashand Short Term Investments	0.48	0.27	0.11	0.51
Accounts Receivable- Trade Net	100.09	76.33	68.57	50.62
Total Receivables Net	100.09	84.37	74.68	53.35
Total Inventory	43.76	47.28	42.55	34.24
Other Current Assets Total	5.66	0.55	0.54	1.15
Total Current Assets	149.98	132.48	117.88	89.25
Property/ Plant/ Equipment Total- Net	71.67	63.96	57.00	43.64
Intangibles Net	1.68	2.10	-	-
Long Term Investments	1.32	0.08	0.08	0.08
Other Long Term Assets Total	2.07	3.00	2.78	2.19
Total Assets	226.72	201.85	178.00	135.38
Accounts Payable	110.65	95.10	79.53	54.74
Current Portof LT Debt/ Capital Leases	43.15	5.41	6.39	4.11
Other Currentliabilities Total	6.30	3.09	5.24	8.51
Total Current Liabilities	160.10	137.58	112.56	77.36
Long Term Debt	14.64	12.28	13.34	6.99
Total Long Term Debt	14.64	12.28	13.34	6.99
Total Debt	57.79	51.67	41.13	21.10
Deferred Income Tax	4.52	4.15	3.89	3.58
Other Liabilities Total	1.62	1.63	1.41	0.86
Total Liabilities	180.88	155.63	131.20	88.80
Common Stock Total	8.00	8.00	8.00	8.00
Retained Earnings( Accumulated Deficit)	37.84	34.49	35.07	34.85
Total Equity	45.84	46.21	46.80	46.58
Total Liabilities Shareholders' Equity	226.72	201.85	178.00	135.38
Total Common Shares Outstanding	0.80	0.80	0.80	0.80
Tangible Book Valueper Share Common Eq	55.20	55.15	58.50	58.22
Property/ Plant/ Equipment Total- Gross	-	110.71	99.44	82.28
Accumulated Depreciation Total	-	-46.76	-42.44	-38.64
Note Receivable- Long Term	-	0.23	0.26	0.21
Notes Payable/ Short Term Debt	-	33.99	21.41	10.00
Additional Paid- In Capital	-	3.73	3.73	3.73